Perrigo (PRGO) Non-Current Assets (2013 - 2026)
Perrigo (PRGO) reported Non-Current Assets of $5.3 billion for Q1 2026, down 27.06% year-over-year from $7.2 billion in Q1 2025, and down 8.14% quarter-over-quarter from $5.7 billion in Q4 2025.
Perrigo (PRGO) Non-Current Assets (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Non-Current Assets data on file, last reported at $5.3 billion in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $5.3 billion, down 27.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 billion (down 27.06% YoY), and the FY2025 annual result was $5.7 billion, down 19.93% from the prior year.
- Non-Current Assets declined to $5.3 billion in Q1 2026 per PRGO's latest filing, from $5.7 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $8.3 billion in Q4 2022 and troughed at $5.3 billion in Q1 2026.
- A 5-year average of $7.4 billion and a median of $7.5 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2026: Non-Current Assets rose 27.27% in 2023, then slipped 27.06% in 2026.
- A 5-year view of Non-Current Assets shows it stood at $8.3 billion in 2022, then decreased by 3.87% to $8.0 billion in 2023, then decreased by 10.16% to $7.2 billion in 2024, then dropped by 19.93% to $5.7 billion in 2025, then fell by 8.14% to $5.3 billion in 2026.
- Business Quant data shows PRGO's Non-Current Assets at $5.3 billion in Q1 2026, $5.7 billion in Q4 2025, and $7.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 5.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 5.27 Bn |
| Dec 31, 2025 | 5.74 Bn |
| Sep 27, 2025 | 7.20 Bn |
| Jun 28, 2025 | 7.48 Bn |
| Mar 29, 2025 | 7.23 Bn |
| Dec 31, 2024 | 7.17 Bn |
| Sep 28, 2024 | 7.50 Bn |
| Jun 29, 2024 | 7.44 Bn |
| Mar 30, 2024 | 7.83 Bn |
| Dec 31, 2023 | 7.98 Bn |
| Sep 30, 2023 | 7.99 Bn |
| Jul 1, 2023 | 8.19 Bn |
| Apr 1, 2023 | 8.21 Bn |
| Dec 31, 2022 | 8.30 Bn |
| Oct 1, 2022 | 8.09 Bn |
| Jul 2, 2022 | 8.27 Bn |
| Apr 2, 2022 | 6.45 Bn |
| Dec 31, 2021 | 6.57 Bn |
| Oct 2, 2021 | 6.69 Bn |
| Jul 3, 2021 | 6.81 Bn |